Nasdaq

U.S. Food and Drug Administration Approves BioMarin's VOXZOGO® (vosoritide) for Children Under 5 Years with Achondroplasia

Expanded Indication in the U.S. Now Includes Children of all ages with Achondroplasia BioMarin conducted a randomized, double-blind, placebo-controlled Phase 2 clinical trial evaluating the safety and ...
Nasdaq

FDA Approves BioMarin Pharma's Voxzogo For Children Under 5 Years With Achondroplasia

(RTTNews) - BioMarin Pharmaceutical Inc. (BMRN) said Friday that the U.S. Food and Drug Administration has approved the supplemental New Drug Application or sNDA for Voxzogo (vosoritide) to increase ...
Healio

FDA expands indication for vosoritide to include children of all ages with achondroplasia

Please provide your email address to receive an email when new articles are posted on . The FDA has expanded its accelerated approval for vosoritide to include children of all ages with achondroplasia ...
The American Journal of Managed Care

Vosoritide Approved for Achondroplasia in Children Under 5 Years by FDA

Children of all ages with achondroplasia are now included in the expanded Indication, the most common form of skeletal dysplasia leading to disproportionate short stature. This article was originally ...
Monthly Prescribing Reference

Voxzogo Approval Expanded to Younger Children With Achondroplasia

Credit: BioMarin. The expanded approval was based on data from a phase 2 trial that included children less than 5 years of age with achondroplasia. The Food and Drug Administration (FDA) has expanded ...
Healio

FDA approves Voxzogo, first drug to improve growth in common form of dwarfism

Please provide your email address to receive an email when new articles are posted on . The FDA granted accelerated approval to vosoritide injection to improve growth among children aged 5 years or ...
Pharmabiz

US FDA approves BioMarin’s Voxzogo for children of all ages with achondroplasia

BioMarin Pharmaceutical Inc., a global biotechnology company dedicated to transforming lives through genetic discovery, announced that the US Food and Drug Administration (FDA) has approved the ...